Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maravai Lifesciences Holdings (MRVI) Total Debt (2020 - 2025)

Historic Total Debt for Maravai Lifesciences Holdings (MRVI) over the last 6 years, with Q3 2025 value amounting to $292.8 million.

  • Maravai Lifesciences Holdings' Total Debt fell 4387.42% to $292.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $292.8 million, marking a year-over-year decrease of 4387.42%. This contributed to the annual value of $295.9 million for FY2024, which is 4354.03% down from last year.
  • Latest data reveals that Maravai Lifesciences Holdings reported Total Debt of $292.8 million as of Q3 2025, which was down 4387.42% from $293.9 million recorded in Q2 2025.
  • Maravai Lifesciences Holdings' 5-year Total Debt high stood at $750.3 million for Q3 2021, and its period low was $292.8 million during Q3 2025.
  • Its 5-year average for Total Debt is $545.8 million, with a median of $525.8 million in 2023.
  • Per our database at Business Quant, Maravai Lifesciences Holdings' Total Debt skyrocketed by 4006.81% in 2022 and then plummeted by 4387.42% in 2025.
  • Maravai Lifesciences Holdings' Total Debt (Quarter) stood at $748.3 million in 2021, then dropped by 29.52% to $527.4 million in 2022, then decreased by 0.62% to $524.1 million in 2023, then tumbled by 43.54% to $295.9 million in 2024, then dropped by 1.05% to $292.8 million in 2025.
  • Its last three reported values are $292.8 million in Q3 2025, $293.9 million for Q2 2025, and $294.9 million during Q1 2025.